Ethics of Surrogate Consent for Dementia Research
痴呆症研究的替代同意的伦理
基本信息
- 批准号:7494584
- 负责人:
- 金额:$ 37.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-15 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAlzheimer&aposs DiseaseAmericanAttitudeAuthorization documentationBeliefBenefits and RisksBrainComplementConsentConsultationsDataDecision MakingDementiaDemocracyDepthEducationElderly womanEnrollmentEquilibriumEthicsEthnic OriginEventFamilyFamily memberFutureGeneral PopulationGuidelinesHealthIndividualInterventionKnowledgeMeasuresMethodsMinority GroupsModelingParticipantPersonsPhasePoliciesPolicy ResearchProceduresProtocols documentationPublished CommentRaceRecording of previous eventsResearchResearch EthicsResearch Ethics CommitteesResearch MethodologyResearch PersonnelRiskSeriesSerious Adverse EventSpousesSurveysVolunteerismWorkWritingbasedaydesigninnovationinsightmembermultidisciplinaryracial and ethnicresearch studysocialtheoriesvolunteerwillingness
项目摘要
DESCRIPTION (provided by applicant): Enrolling adults with decisional incapacity in dementia research based on surrogate permission (surrogate-based research, or SBR) is increasingly practiced but without widely accepted policy guidelines, despite decades of controversy. Policy is especially vague when the research poses significant risks but holds little or no prosepect for direct benefit to the subjects. The need for clearer policy is acute, as serious adverse events increasingly occur in innovative, early phase Alzheimer's disease research studies. This project will address an important gap in our knowledge regarding SBR policy: the perspectives of a key lay stakeholder group (family surrogates) and of the older general public, regarding the appropriateness of surrogate consent for research with significant risks and little or no potential for benefit. This proposal combines two complementary projects to maximize generalizability and internal validity. First, a nationally representative survey of the older public's views regarding SBR will generate the first broadly generalizable data on this issue. It will also allow an examination of the key correlates of individuals' attitudes toward SBR in several domains (racial and ethnic background, social relational factors, volunteerism and civic mindedness, among others). Second, a series of day-long deliberative democratic (DD) consultation sessions with family members of persons with dementia and with members of the older general public will be conducted. The DD project optimizes internal validity by providing balanced education and promoting facilitated deliberations among participants and by an experimental, controlled design to measure its effect. The DD project's quantitative results will be enriched by a thorough in-depth qualitative analysis of DD sessions to provide further insights into people's attitudes towards SBR. This proposal brings together experts in dementia research, research ethics, deliberative democracy theory and practice, survey research, and mixed methods research. A multidisciplinary Advisory Panel will add objectivity and balance to the content of the DD sessions. The results of this project will inform the work of research ethics policymakers, policy-implementers (such as IRBs), researchers in their recruitment of incapacitated subjects, and family members who may act as surrogates for research consent.
描述(由申请人提供):招募有决策能力丧失能力的成年人参加基于代理许可的痴呆症研究(基于代理的研究,或SBR)的做法越来越多,但没有广泛接受的政策指导方针,尽管存在数十年的争议。当研究带来重大风险,但几乎不能或根本不能为受试者带来直接利益时,政策就特别模糊。迫切需要更明确的政策,因为在创新的早期阿尔茨海默病研究中,严重的不良事件越来越多地发生。这个项目将解决我们对SBR政策认识上的一个重要差距:一个关键的非专业利益相关者群体(家庭代孕)和老年公众的观点,即代孕同意对于具有重大风险和很少或没有潜在好处的研究是否合适。该提案结合了两个互补项目,以最大限度地提高概括性和内部有效性。首先,对老年公众对SBR的看法进行的具有全国代表性的调查将产生关于这一问题的第一个可广泛推广的数据。它还将允许在几个领域(种族和民族背景、社会关系因素、志愿精神和公民意识等)检查个人对SBR的态度的关键相关因素。第二,将与痴呆症患者的家人和年长的公众人士举行一连串为期一天的协商民主咨询会议。发展与发展项目通过提供均衡的教育,促进参与者之间的讨论,并通过试验性的受控设计来衡量其效果,优化了内部效度。发展与发展项目的量化结果将通过对发展与发展会议进行彻底深入的定性分析而得到丰富,以进一步深入了解人们对SBR的态度。这项建议汇集了痴呆症研究、研究伦理、协商民主理论和实践、调查研究和混合方法研究方面的专家。多学科咨询小组将为发展司会议的内容增加客观性和平衡性。该项目的结果将为研究伦理政策制定者、政策实施者(如IRBs)、招募无行为能力受试者的研究人员以及可作为研究同意代理人的家庭成员的工作提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott Y Kim其他文献
Scott Y Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott Y Kim', 18)}}的其他基金
Therapeutic Misconception and the Ethics of Sham Surgery Controls in PD Research
PD 研究中的治疗误解和假手术控制伦理
- 批准号:
7650502 - 财政年份:2009
- 资助金额:
$ 37.92万 - 项目类别:
Therapeutic Misconception and the Ethics of Sham Surgery Controls in PD Research
PD 研究中的治疗误解和假手术控制伦理
- 批准号:
8026012 - 财政年份:2009
- 资助金额:
$ 37.92万 - 项目类别:
Ethics of Surrogate Consent for Dementia Research
痴呆症研究的替代同意的伦理
- 批准号:
7313285 - 财政年份:2007
- 资助金额:
$ 37.92万 - 项目类别:
Ethics of Surrogate Consent for Dementia Research
痴呆症研究的替代同意的伦理
- 批准号:
7626708 - 财政年份:2007
- 资助金额:
$ 37.92万 - 项目类别:
Ethics of Surrogate Consent for Dementia Research
痴呆症研究的替代同意的伦理
- 批准号:
7892357 - 财政年份:2007
- 资助金额:
$ 37.92万 - 项目类别:
Capacity to Appoint a Proxy for Research Consent
指定研究同意代理人的能力
- 批准号:
7489849 - 财政年份:2005
- 资助金额:
$ 37.92万 - 项目类别:
Capacity to Appoint a Proxy for Research Consent
指定研究同意代理人的能力
- 批准号:
7110978 - 财政年份:2005
- 资助金额:
$ 37.92万 - 项目类别:
Capacity to Appoint a Proxy for Research Consent
指定研究同意代理人的能力
- 批准号:
7676842 - 财政年份:2005
- 资助金额:
$ 37.92万 - 项目类别:
Capacity to Appoint a Proxy for Research Consent
指定研究同意代理人的能力
- 批准号:
6960892 - 财政年份:2005
- 资助金额:
$ 37.92万 - 项目类别:
Capacity to Appoint a Proxy for Research Consent
指定研究同意代理人的能力
- 批准号:
7275290 - 财政年份:2005
- 资助金额:
$ 37.92万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.92万 - 项目类别:
Research Grant